Uroplasty, Inc (UPI) - NASDAQ
  • Jan. 23, 2015, 12:46 PM
    | Jan. 23, 2015, 12:46 PM | 3 Comments
  • Aug. 12, 2014, 12:45 PM
    | Aug. 12, 2014, 12:45 PM | 2 Comments
  • Jan. 24, 2014, 12:47 PM
    | Jan. 24, 2014, 12:47 PM | 1 Comment
  • Dec. 6, 2013, 12:48 PM
    | Dec. 6, 2013, 12:48 PM
  • Sep. 3, 2013, 2:42 PM
    • Uroplasty (UPI +4.8%) says a class action lawsuits filed against the company alleging possible violations of federal securities laws in relation to the delayed filing of its 10K earlier this year has been dismissed. No payment or consideration of any kind was made by URI in connection with these lawsuits.
    | Sep. 3, 2013, 2:42 PM
  • Aug. 12, 2013, 9:48 AM
    • Uroplasty (UPI -6%), a provider of devices for treating voiding dysfunctions, names Brett Reynolds as CFO.
    • Reynolds most recently held the same position at Synovis Life Technologies, which was sold to Baxter International in February 2012 for $325M. (PR)
    | Aug. 12, 2013, 9:48 AM
  • Aug. 2, 2013, 3:18 PM
    • Uroplasty (UPI +17%) pops today after saying Medicare administrative contractor Novitas Solutions has expanded coverage for posterior tibial nerve stimulation using the company's Urgent PC neuromodulation system to treat overactive bladder and associated symptoms.
    • The increased coverage includes additional diagnostic codes as well as expansion of on-going therapy from 12 months to up to two years.
    • The company also reported FQ1 earnings last night that largely trailed analysts forecasts. (PR)
    | Aug. 2, 2013, 3:18 PM
  • Jul. 23, 2013, 12:45 PM
    Midday top 10 gainers: UPI +42%. IPCI +30%. FIRE +28%. CSE +22%. USU +19%. DLIA +19%. SMSI +16%. URRE +16%. PRAN +14%. HSTM +14%. Midday top 10 Losers: CTG -22%. ALGT -13%. HGSH -13%. OME -10%. SPTN -10%. NAFC -10%. EMITF -9%. SILC -9%. DRTX -9%. STM -8%.
    | Jul. 23, 2013, 12:45 PM
  • Jun. 14, 2013, 12:45 PM
    Midday top 10 gainers: BCSB +31%. RH +18%. CDXS +17%. SGOC +17%. BLIN +16%. LGL +15%. RVLT +13%. GRPN +13%. UNXL +12%. FMAR +12%.
    Midday top 10 Losers: CEMP -14%. OSH -14%. UNTK -13%. UPI -12%. EDAP -12%. CPST -11%. OCLS -11%. CLSN -10%. AMSC -9%. ACH -9%.
    | Jun. 14, 2013, 12:45 PM
  • Jun. 14, 2013, 6:58 AM

    Uroplasty (UPI) indicates it will delay filing its annual report until it completes a review of internal controls concerning employee expense reimbursements. UPI -16.4% premarket.

    | Jun. 14, 2013, 6:58 AM
  • May 31, 2013, 12:57 PM
    Midday top 10 gainers: GIGA +29%. UPI +23%. OSH +22%. OVTI +19%. TELK +18%. LAS +18%. HGSH +18%. KKD +17%. CEP +14%. MGCD +13%.
    Midday top 10 Losers: MNGA -22%. UNXL -19%. PLM -13%. PANW -9%. PW -9%. ECTY -9%. ICA -9%. RSOL -9%. NGD -9%. FSM -9%.
    | May 31, 2013, 12:57 PM
  • May 30, 2013, 7:45 PM

    More on Uroplasty (UPI): Q4 misses across the board as total sales slipped 1% year over year. U.S. sales increased 2%, driven by an 11% increase in sales of the Urgent(R) PC Neuromodulation System, but global sales declined 1% to $5.5M. Additionally, the company said that Wisconsin Physicians Services, a Medicare Administrative Contractor providing benefits to approximately 8.7M Medicare beneficiaries in nine Midwestern states, will begin coverage for its Posterior Tibial Nerve Stimulation device as a treatment for overactive bladders and associated symptoms starting June 1. Shares +9.8% AH.

    | May 30, 2013, 7:45 PM
  • Apr. 5, 2013, 10:19 AM

    Uroplasty (UPI -6.6%) slides after announcing the resignation of CEO David Kaysen. The company also guided below estimates for both Q4 and FY13 revenue. 

    | Apr. 5, 2013, 10:19 AM
  • Jan. 30, 2013, 12:45 PM
    Midday top 10 gainers: MERU +40%. CWBC +21%. BIOC +19%. MGAM +17%. FSL +17%. HTCH +17%. DLHC +17%. CPNO +14%. USAK +14%. IBCP +14%.
    Midday top 10 Losers: VTUS -21%. KTCC -18%. MTOR -16%. HA -13%. ATTU -12%. CODE -12%. CEVA -12%. AUDC -11%. TRMD -10%. UPI -9%.
    | Jan. 30, 2013, 12:45 PM | 3 Comments
  • Jan. 22, 2013, 12:45 PM
    Midday top 10 gainers: PBIB +32%. DQ +18%. TECUA +18%. ONP +17%. USEG +17%. RDCM +17%. CIMT +14%. BOX +14%. MTRX +12%. PRCP +12%.
    Midday top 10 Losers: CALI -12%. OIBR -12%. BVX -10%. DOM -9%. ARNA -8%. IIVI -8%. AMRI -8%. UPI -8%. IPXL -8%. EXFO -7%.
    | Jan. 22, 2013, 12:45 PM
  • Oct. 10, 2012, 12:45 PM
    Midday top 10 gainers: CLNT +28%. TRLG +23%. AUQ +17%. KGN +15%. PBM +14%. OTT +12%. BLIN +19%. KID +12%. VVTV +12%. ECTE +9%.
    Top 10 Losers: OCZ -40%. ACW -32%. FOE -24%. GLUU -14%. BSET -11%. HELE -10%. BSDM -10%. UPI -10%. AMRN -10%. TZYM -9%.
    | Oct. 10, 2012, 12:45 PM
Company Description
Uroplasty Inc a medical device company. It develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States